Alice T. Shaw
Harvard University(US)Signum Biosciences (United States)(US)Dana-Farber Cancer Institute(US)Novartis (United States)(US)Dana-Farber/Harvard Cancer Center(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Cancer therapeutics and mechanisms
Most-Cited Works
- → Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer(2010)4,491 cited
- → Tumour heterogeneity and resistance to cancer therapies(2017)3,630 cited
- → Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors(2011)3,534 cited
- → Crizotinib versus Chemotherapy in Advanced ALK -Positive Lung Cancer(2013)3,388 cited
- → Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer(2017)2,414 cited
- → Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer(2014)1,982 cited